RILEXINE® (cephalexin tablets) Chewable Tablets
The first and only veterinary-approved cephalexin that meets the needs of patients, pet owners, and veterinarians. For the treatment of secondary superficial bacterial pyoderma.
- Tasty chicken liver flavor that dogs readily accept (unlike human formulations
- Simpler administration to support pet owner compliance, especially when being administered over many days
- More precise dosing with scored tablets for accurate treatment of dogs of any size (unlike human formulations)
- Three tablet sizes in dosage strengths that help ensure more accurate dosing: 150 mg, 300 mg, and 600 mg
Important Safety Information
RILEXINE® (cephalexin tablets) Chewable Tablets: For oral use in dogs only.
RILEXINE® Tablets are very palatable for pets and should be stored in a secure location where pets cannot access them.
Do not give to dogs with known allergy to penicillins or cephaloporins. People with sensitivities to penicillins or cephalosporins
should avoid contact with this product. Safety in breeding, pregnant, or lactating dogs has not been evaluated. The most common adverse reactions in dogs include diarrhea, vomiting, anorexia and lethargy. For complete information or to obtain a package insert, contact Virbac at 1‐800‐338‐3659, or download here.
Ingredients:
RILEXINE tablets are supplied in four tablet sizes containing 75 mg, 150 mg, 300 mg, or 600 mg of cephalexin.
